JP Morgan Chase’s Adeptus Health Inc ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-26,561
Closed -$48K 5482
2017
Q1
$48K Sell
26,561
-55,233
-68% -$310K ﹤0.01% 4539
2016
Q4
$625K Buy
81,794
+68,098
+497% +$1.25M ﹤0.01% 3652
2016
Q3
$590K Buy
13,696
+9,554
+231% +$431K ﹤0.01% 3343
2016
Q2
$214K Sell
4,142
-27,263
-87% -$1.63M ﹤0.01% 3701
2016
Q1
$1.74M Buy
31,405
+3,130
+11% +$162K ﹤0.01% 2773
2015
Q4
$1.54M Buy
+28,275
New +$1.8M ﹤0.01% 2898

Other funds holding ADPT

JP Morgan Chase's ADPT Position: Q2 2017 in Review

JP Morgan Chase sold out of Adeptus Health Inc (ADPT) in Q2 2017, closing a stake of 26,561 shares — an estimated $48K sold.

JP Morgan Chase first reported a position in ADPT in Q4 2015 and held it in 6 quarters. The position peaked at $1.74M in Q1 2016. 9 funds tracked by Wall St. Rank hold ADPT as of Q2 2017.

  • JP Morgan Chase reported no remaining Adeptus Health Inc position as of Q2 2017 after selling out during the quarter.
  • JP Morgan Chase sold 26,561 Adeptus Health Inc shares in Q2 2017, an estimated $48K.
  • JP Morgan Chase first reported a position in Adeptus Health Inc in Q4 2015 and held it in 6 quarters.
  • JP Morgan Chase's Adeptus Health Inc position peaked at $1.74M in Q1 2016.
  • 9 funds tracked by Wall St. Rank held Adeptus Health Inc as of Q2 2017.

Based on JP Morgan Chase's 13F filing for Q2 2017, filed 9 Aug 2017.